Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...

The PAH treatment market is expected to grow from USD 5,811.5 million in 2023 to USD 7,224.4 million by 2033, at a CAGR of 2.2%. Complementary therapies, including exercise programs and oxygen therapy ...

Celastrol, a herbal compound in traditional Chinese medicine, may help prevent BPD-PH by reducing inflammation and protecting ...

If you have high blood pressure, medication may be an important part of the plan to keep you healthy. Also called antihypertensive medicines, these drugs can't cure high blood pressure but can ...

Erika Berman Rosenzwieg, M.D., is the head of pediatrics at New York Medical College School of Medicine and the affiliated ...

Dozens of different medications can help treat high blood pressure (hypertension). These medications are called antihypertensives and are divided into many different categories, each of which ...

The high prevalence of anorexigen use in patients with SPH also raises the possibility that these drugs precipitate pulmonary hypertension in patients with underlying conditions associated with SPH.

Pulnovo Medical, a developer of medical devices for pulmonary hypertension and heart failure, has closed its oversubscribed Series C funding round at nearly $100 million to advance global clinical ...

Pulmonary hypertension, despite advances in treatment, still has a poor prognosis, which is often associated with right heart failure, and for which pulmonary arterial hypertension (PAH) is a severe ...